MedTrace Logo

CT Abnormalities Evocative of Lung Infection Are Associated With Lower 18F-FDG Uptake in Confirmed COVID-19 Patients

NCT04512118 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 22

Last updated 2020-08-13

No results posted yet for this study

Summary

CT signs that are evocative of lung COVID-19 infections have been extensively described, whereas 18F-FDG-PET signs have not. Our current study aimed to identify specific COVID-19 18F-FDG-PET signs in patients that were (i) suspected to have a lung infection based on 18F-FDG-PET/CT recorded during the COVID-19 outbreak and (ii) whose COVID-19 diagnosis was definitely established or excluded by appropriate viral testing.

Conditions

  • Presence of COVID-19 Compatible CT Abnormalities

Interventions

DIAGNOSTIC_TEST

PET-CT of 18F-FDG

Whole-body 18F-FDG-PET/CT was performed on a digital hybrid system (Vereos, Philips®)

Sponsors & Collaborators

  • Central Hospital, Nancy, France

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-15
Primary Completion
2020-06-30
Completion
2020-07-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04512118 on ClinicalTrials.gov